432 related articles for article (PubMed ID: 27834814)
1. The Role of CC-Chemokines in the Regulation of Angiogenesis.
Ridiandries A; Tan JT; Bursill CA
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814
[TBL] [Abstract][Full Text] [Related]
2. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.
Ridiandries A; Tan JT; Ravindran D; Williams H; Medbury HJ; Lindsay L; Hawkins C; Prosser HC; Bursill CA
FASEB J; 2017 Mar; 31(3):1179-1192. PubMed ID: 27998907
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic properties of artemisinin derivatives (Review).
Wei T; Liu J
Int J Mol Med; 2017 Oct; 40(4):972-978. PubMed ID: 28765885
[TBL] [Abstract][Full Text] [Related]
4. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
[TBL] [Abstract][Full Text] [Related]
5. CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
White GE; Iqbal AJ; Greaves DR
Pharmacol Rev; 2013 Jan; 65(1):47-89. PubMed ID: 23300131
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis.
Schoettler N; Brahn E
Curr Opin Investig Drugs; 2009 May; 10(5):425-33. PubMed ID: 19431075
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
Griffioen AW; Molema G
Pharmacol Rev; 2000 Jun; 52(2):237-68. PubMed ID: 10835101
[TBL] [Abstract][Full Text] [Related]
8. Ginseng on Cancer: Potential Role in Modulating Inflammation-Mediated Angiogenesis.
Dai D; Zhang CF; Williams S; Yuan CS; Wang CZ
Am J Chin Med; 2017; 45(1):13-22. PubMed ID: 28068835
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis as a potential treatment strategy for rheumatoid arthritis.
Wang Y; Wu H; Deng R
Eur J Pharmacol; 2021 Nov; 910():174500. PubMed ID: 34509462
[TBL] [Abstract][Full Text] [Related]
11. Chemokines and angiogenesis in rheumatoid arthritis.
Szekanecz Z; Pakozdi A; Szentpetery A; Besenyei T; Koch AE
Front Biosci (Elite Ed); 2009 Jun; 1(1):44-51. PubMed ID: 19482623
[TBL] [Abstract][Full Text] [Related]
12. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and angiogenesis.
Szekanecz Z; Koch AE
Curr Opin Rheumatol; 2001 May; 13(3):202-8. PubMed ID: 11333349
[TBL] [Abstract][Full Text] [Related]
14. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics.
Hegde PS; Wallin JJ; Mancao C
Semin Cancer Biol; 2018 Oct; 52(Pt 2):117-124. PubMed ID: 29229461
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of angiogenesis: ready for prime time?
Maracle CX; Tas SW
Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):637-49. PubMed ID: 25481555
[TBL] [Abstract][Full Text] [Related]
16. Targeting of proangiogenic signalling pathways in chronic inflammation.
Tas SW; Maracle CX; Balogh E; Szekanecz Z
Nat Rev Rheumatol; 2016 Feb; 12(2):111-22. PubMed ID: 26633288
[TBL] [Abstract][Full Text] [Related]
17. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
18. Pathological angiogenesis and inflammation in tissues.
Jeong JH; Ojha U; Lee YM
Arch Pharm Res; 2021 Jan; 44(1):1-15. PubMed ID: 33230600
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis as an immunopharmacologic target in inflammation and cancer.
Bian XW; Chen JH; Jiang XF; Bai JS; Wang QL; Zhang X
Int Immunopharmacol; 2004 Nov; 4(12):1537-47. PubMed ID: 15351323
[TBL] [Abstract][Full Text] [Related]
20. Cancer CXC chemokine networks and tumour angiogenesis.
Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
